Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;12(4):496-503.
doi: 10.1007/s44197-022-00068-y. Epub 2022 Sep 29.

Clinicopathological Correlations in Enucleated Globes of Late-Stage Coats Disease with a Review of the Literature

Affiliations
Review

Clinicopathological Correlations in Enucleated Globes of Late-Stage Coats Disease with a Review of the Literature

Hala A Helmi et al. J Epidemiol Glob Health. 2022 Dec.

Abstract

Background: Coats disease may cause diagnostic dilemma because of its variable clinical presentation that can be suspicious of retinoblastoma. Late sequelae of the disease are blinding with possible enucleation. We demonstrate the main histopathological findings of Coats enucleated eyes with literature review.

Methods: This was a retrospective study of all enucleated globes diagnosed as Coats disease over 30 years and were reviewed by two pathologists. The corresponding demographic data, clinical presentation, pre-operative clinical impression, and indication for enucleation were collected. Descriptive analysis of our own series data was performed. Our findings were then correlated to published data that were collected from 1983 to 2021 from the PUBMED database in English-written language. Shields classification was used as an inclusion criterion for the published reports to be analyzed.

Results: We had seven enucleated globes with Coats disease. Mean age at presentation was 3.2 years (range 3 months to 9 years). Male predominance was observed in 6 and all cases were unilateral. Strabismus was the most common initial presentation (57%, n = 4), followed by leukocoria (43%, n = 3). Indication for enucleation was mostly suspected retinoblastoma (57%, n = 4). Four eyes were classified as stage 4, and 2 had advanced stage 5 changes. Histopathologically, subretinal fluid with lipid-laden macrophages was seen in all cases, the anterior chamber was shallow in 5/7 with angle neovascularization in 2/7. Telangiectatic vessels were clearly observed in 4/7.

Conclusion: Coats disease is a potentially visually disabling disease that is mostly unilateral in 95%, has male predominance of 81%, and wide age range with a mean of 17 years. In Saudi Arabia, the disease seems to present at younger age, tends to be more advanced, and may be indistinguishable from retinoblastoma at the time of diagnosis. Shields staging of Coats is highly recommended to be followed clinically to unify the pathways for treatment and to correlate the concluded outcomes.

Keywords: Coats disease; Enucleation; Globe; Leukocoria; Retinoblastoma; Subretinal exudate.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest or financial disclosures in relation to this work.

Figures

Fig. 1
Fig. 1
A Obliterated anterior chamber angle (white arrowhead) with atrophic iris and retro-lental (black arrow pointing at the lens) proteinaceous hemorrhagic fluid (original magnification X50 Hematoxylin & eosin). B An atrophic optic nerve head (ON) with overlying total retinal detachment (RD) (original magnification × 100 Hematoxylin & eosin). C Retinal shallow detachment with subretinal fluid (white arrowhead) and abnormal retinal blood vessels (original magnification × 100 Hematoxylin & eosin). D The subretinal fluid with fresh hemorrhage and cholesterol clefts (black arrow) indicating old hemorrhage (original magnification × 200 Hematoxylin & eosin)
Fig. 2
Fig. 2
A A focus of shallow retinal detachment with subretinal fluid (white arrowhead), abnormal retinal vasculature and telangiectatic blood vessels (black arrow) near the ora serrata (original magnification × 100 Hematoxylin & eosin). B Cholesterol clefts and foamy histiocytes within the sensory retina (original magnification X100 Hematoxylin & eosin). C Higher power of the foamy macrophages (black arrows) with giant cell formation (original magnification × 200 Hematoxylin & eosin). D Subretinal exudate with cholesterol clefts and pigment dispersion in another case of Coat’s Disease (original magnification × 200 Hematoxylin & eosin)

References

    1. Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: the 2000 Proctor Lecture. Am J Ophthalmol [Internet]. 2001;131(5):572–583. doi: 10.1016/S0002-9394(01)00896-0. - DOI - PubMed
    1. Yang X, Wang C, Su G. Recent advances in the diagnosis and treatment of Coats’ disease. Int Ophthalmol [Internet]. 2019;39(4):957–970. doi: 10.1007/s10792-019-01095-8. - DOI - PubMed
    1. Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol [Internet]. 2001;131(5):561–571. doi: 10.1016/S0002-9394(00)00883-7. - DOI - PubMed
    1. Shields JA, Shields CL. Review: coats disease: the 2001 LuEsther T. Mertz lecture. Retina [Internet]. 2002;22(1):80–91. doi: 10.1097/00006982-200202000-00014. - DOI - PubMed
    1. Rishi E, Rishi P, Appukuttan B, Uparkar M, Sharma T, Gopal L. Coats' disease of adult-onset in 48 eyes. Indian J Ophthalmol. 2016;64(7):518–523. doi: 10.4103/0301-4738.190141. - DOI - PMC - PubMed

LinkOut - more resources